Effect of weight on outcomes of children undergoing hematopoietic cell transplantation

Pediatric Hematology and Oncology

Volumn 30, Issue 2, 2013, Pages 116-130

  Myers, Laura C ^a   Sun, Pengling ^b   Brennan, Lisa L ^c   London, Wendy B ^b   Guinan, Eva C ^b,c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Bone marrow transplant; Children; Obesity

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BLAST CELL CRISIS; BODY WEIGHT; CANCER MORTALITY; CHILD; CHILDHOOD OBESITY; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; FEMALE; HUMAN; JUVENILE MYELOMONOCYTIC LEUKEMIA; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; LUNG TOXICITY; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; NEPHROTOXICITY; OVERALL SURVIVAL; PRESCHOOL CHILD; REFRACTORY ANEMIA; RETROSPECTIVE STUDY; SCHOOL CHILD; TREATMENT OUTCOME;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; NEOPLASMS; OBESITY; RETROSPECTIVE STUDIES; SURVIVAL RATE; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 84873913089     PISSN: 08880018     EISSN: 15210669     Source Type: Journal    
DOI: 10.3109/08880018.2012.743201     Document Type: Article

References (32)

1. Hedley AA, Ogden CL, Johnson CL, et al. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. JAMA. 2004;291(23):2847-2850.
2. Dietz WH. Health consequences of obesity in youth: childhood predictors of adult disease. Pediatrics. 1998;101:518-525.
3. Rodriguez MA, Winkleby MA, Ahn D, et al. Identification of population subgroups of children and adolescents with high asthma prevalence: findings fromthe Third NationalHealth andNutrition Examination Survey. Arch Pediatr AdolescMed. 2002;156(3):269-275.
4. Mallory GB Jr, FiserDH, Jackson R. Sleep-associated breathing disorders inmorbidly obese children and adolescents. J Pediatr. 1989;115(6):892-897.
5. Fagot-Campagna A, Narayan KM, Imperatore G. Type 2 diabetes in children. BMJ. 2001;322(7283):377-378.
6. Taylor ED, Theim KR,Mirch MC, et al. Orthopedic complications of overweight in children and adolescents. Pediatrics. 2006;117(6):2167-2174.
7. Tait AR, Voepel-Lewis T, Burke C, et al. Incidence and risk factors for perioperative adverse respiratory events in children who are obese. Anesthesiology. 2008;108(3):375-380.
8. Nafiu OO, Reynolds PI, Bamgbade OA, et al. Childhood bodymass index and perioperative complications. Paediatr Anaesth. 2007;17(5):426-430.
9. Rogers PC, Meacham LR, Oeffinger KC, et al. Obesity in pediatric oncology. Pediatr Blood Cancer. 2005;45(7):881-891.
10. NavarroWH. Impact of obesity in the setting of high dose chemotherapy. Bone Marrow Transplant. 2003;31(11):961-966.
11. Wong M, Balleine RL, Blair EY, et al. Predictors of vinorelbine pharmacokinetics and pharmacodynamics in patients with cancer. J Clin Oncol. 2006;24(16):2448-2455.
12. Griggs JJ, Mangu PB, Anderson H, et al. Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol. 2012;30(99):1-10.
13. Navarro WH, Loberiza FR Jr, Bajorunaite R, et al. Effect of body mass index on mortality of patients with lymphoma undergoing autologous hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2006;12(5):541-551.
14. Dickson TM, Kusnierz-Glaz CR, Blume KG, et al. Impact of admission body weight and chemotherapy dose adjustment on the outcome of autologous bonemarrowtransplantation. Biol BloodMarrow Transplant. 1999;5(5):299-305.
15. Tarella C, Caracciolo D, Gavarotti P, et al. Overweight as an adverse prognostic factor for non-Hodgkin's lymphoma patients receiving high dose chemotherapy and autograft. BoneMarrowTransplant. 2000;26(11):1185-1191.
16. Meloni G, Proia A, Capria S, et al. Obesity and autologous stem cell transplantation in acutemyeloid leukemia. Bone Marrow Transplant. 2001;28(4):365-367.
17. Fuji S, Kim SW, Yoshimura K, et al. Possible association between obesity and posttransplantation complications including infectious diseases and acute graft-versus-host disease. Biol Blood Marrow Transplant. 2009;15(1):73-82.
18. Bulley S,Gassas A,Dupuis LL, et al. Inferior outcomes for overweight children undergoing allogeneic stem cell transplantation. Br J Haematol. 2008;140(2):214-217.
19. Barker CC, AgoviMA, Logan B , et al. Childhood obesity and outcomes after bonemarrowtransplantation for patients with severe aplastic anemia. Biol Blood Marrow Transplant. 2010;17(5):737-744.
20. CDC Home. BMI percentile calculator for child and teen,metric version. http://apps.nccd.cdc.gov/dnpabmi/Calculator.aspx?CalculatorType=Metric. AccessedMay 12, 2012.
21. Barlo.w, SE and the Expert Committee. Expert committee recommendations regarding the prevention, assessment and treatment of child and adolescent overweight and obesity: summary report. Pediatrics. 2007;120(Suppl 4);164-192.
22. Group BMI Calculator, English, v1.1. Produced by CDC. www.cdc.gov/healthyweight/. . ./BMI group calculator English.xls. Accessed August 31, 2012.
23. Thornley I, Lehmann LE, Sung L, et al. A multiagent strategy to decrease regimen-related toxicity in children undergoing allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2004;10:635-644.
24. Matthes-Martin S, PotschgerU, Bergmann K, et al. Risk-adjusted outcomemeasurement in pediatric allogeneic stem cell transplantation. Biol Blood Marrow Transplant. 2008;14(3):335-343.
25. National Cancer Institute. Common Terminology Criteria for Adverse Events v3.0. (NIH Publication No. 03-5410. Revised June 2003). National Cancer Institute, 2006.
26. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Statist Assoc. 1958;53:457-481.
27. Cox DR. Regression models and life tables. J Roy Stat Soc, Series B. 1972;34:197-220.
28. Deeg HJ, O'Donnell M, Tolar J, et al. Optimization of conditioning formarrow transplantation from unrelated donors for patients with asplastic anemia after failure of immunosuppressive therapy. Blood. 2006;108(5):1485-1491.
29. Cooke K. Acute lung injury after allogeneic stem cell transplantation: from the clinic, to the bench and back again. Pediatr Transplant. 2005;9(Suppl 7):25-36.
30. Pepe MS,Mori M, Kaplan-M.Marginal or conditional probability curves in summarizing competing risks failure time data? Stat Med. 1993;12(8):737-751.
31. Hale, G. Autologous hematopoietic stem cell transplantation for pediatric solid tumors. Expert Rev Anticancer Ther. 2005;5(5):835-846.
32. CIBMTR Annual Published Data. Summary Slides 2010. Courtesy of Vincent He. Slides 17-19 and 24-38. http://www.cibmtr.org/ReferenceCenter/SlidesReports/ SummarySlides/pages/index.aspx. Accessed December 14, 2010.